Skip to main content

HTRF Human H232 STING Binding Kit, 500 Assay Points

This HTRF assay is designed to select and characterize compounds that specifically bind human H232 STING protein.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Product Variants
Part number: 64BDSTGHPEG
Unit Size: 500 Assay Points
List price: USD 2,091.00
Your price:
USD 2,091.00
USD 2,091.00 /each
Part number: 64BDSTGHPEH
Unit Size: 10,000 Assay Points
List price: USD 24,550.00
Your price:
USD 0.00
USD 24,550.00 /each

Overview

A fast and easy way to identify new binders to human H232 STING.

Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173), is a protein playing a major role in innate immunity.

The H232 variant is found in 13.7% of the world population. Upon intracellular cytosolic DNA release from pathogens such as viruses and bacteria, 2’-3’cGAMP binds to STING protein and triggers the secretion of type 1 interferon. However, the H232 variant is known to poorly bind 2'-3'cGAMP and other natural dinucleotides. The quest for molecules that are effective against all genetic variants has become crucial to modulate immunity in autoinflammatory diseases.

Specifications

Assay Points
500
Assay Target Type
Kit
Assay Technology
HTRF
Brand
HTRF
Quantity
1
Therapeutic Area
Infectious Diseases
Oncology & Inflammation
Unit Size
500 Assay Points

Video gallery

How it works

Assy principle

The HTRF H232 STING binding assay is a competitive assay format which uses d2-labeled H232 STING ligand, a 6His tagged human H232 STING protein, and an anti 6His Cryptate-labeled antibody. Your compound competes with the H232 STING ligand-d2 and thereby prevents FRET from occurring.

human-H232-STING-binding-kit-1.svg
Assay protocol

The Human H232 STING binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, samples or standards are dispensed directly into the assay plate. The human His-tagged H232 STING protein is then added, followed by the dispensing of the HTRF reagents: the anti 6His antibody labeled with Terbium cryptate and  the H232 STING ligand labeled with d2. The reagents labeled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

human-H232-STING-binding-kit-2.svg

 

Assay validation

Compound screening

Various compounds known to be STING ligands were added to the assay.

2'3'cGAMP displays a low affinity for the H232 variant in the µM range, compared its high affinity against WT Sting (Ki=2.5nM). Similarly, the other bacterial compounds such as 3'3' cGAMP, cyclic di-AMP, and cyclic d-GMP, or the reference compound ADU-S100, show Ki constants in the µM.

The assay standard corresponding to a derivative of the labeled ligand is more potent, with a Ki at 13.4nM.

DMXAA, a non-specific compound and also a well-known mouse STING binder, has no effect on the assay, confirming the human specificity of the kit.

human-H232-STING-binding-kit-3.svg

 

Simplified pathway

STING simplified pathway

STING, for STimulator of INterferon Genes, is a cytoplasmic homodimeric protein localized in the endoplasmic reticulum and which plays an essential role in innate immunity. Upon pathogen infection or mitochrondrial shrinking during apoptosis, floating dsDNAs bind and activate a DNA sensor, cyclic GMP-AMP synthase (cGAS). Activated cGAS leads to the production of 2’-3’cGAMP, a cyclic dinucleotide, which then binds to STING proteins. In turn, phosphorylated STING interacts with TANK-binding-kinase-I (TBK1), leading to the recruitment and activation of the active interferon regulatory factor (IRF3) dimer. Nuclear translocation of the IRF3 dimer leads to the transcription of genes encoding IFN-α/β. In addition, the STING pathway controls NF-κB dependent inflammatory cytokine expression. As a negative feedback loop, the DNA-stimulated cGAS-STING-TBK1 pathway also triggers STING protein degradation through p62 SQSTM1 associated autophagy, to switch off IFNb production.

human-H232-STING-binding-kit-4.svg

 

Resources

1-1 of 1 Resources
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon